Skip to main content
SpringerLink
Log in

Accelerating innovation in rapid diagnostics and targeted antibacterials

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Federal Register. E.O. 13676. 79 FR 56931 (2014).

  2. Applications for FDA Approval to Market a New Drug. 21 CFR §314.126 (2009).

  3. Hwang, T.J., Carpenter, D. & Kesselheim, A.S. Science 344, 967–969 (2014).

    Article  CAS  Google Scholar 

  4. Floyd, J.S. & Psaty, B.M. JAMA Intern. Med. 174, 1436–1437 (2014).

    Article  Google Scholar 

  5. Outterson, K. et al. J. Law Med. Ethics 41, 688–696 (2013).

    Article  Google Scholar 

  6. Kesselheim, A.S., Connolly, J., Rogers, J. & Avorn, J. Health Aff. (Millwood) 34, 438–446 (2015).

    Article  Google Scholar 

  7. Silver, L.L. Nat. Biotechnol. 32, 1102–1104 (2014).

    Article  CAS  Google Scholar 

  8. Falagas, M.E. Emerg. Infect. Dis. 20, 1170–1175 (2014).

    Article  Google Scholar 

  9. Darrow, J.J., Avorn, J. & Kesselheim, A.S. N. Engl. J. Med. 371, 89–90 (2014).

    CAS  PubMed  Google Scholar 

  10. Kesselheim, A.S. & Outterson, K. Yale J. Health Policy Law Ethics 11, 101–167 (2011).

    PubMed  Google Scholar 

  11. Sertkaya, A. et al. Eastern Research Group Report for the US Department of Health and Human Services, report no. HHSP23337004T (ERG, Washington, DC, (2014).

  12. Hwang, T.J., Carpenter, D. & Kesselheim, A.S. Sci. Transl. Med. 7, 276fs9 (2015).

    Article  Google Scholar 

Download references

Author information

Author notes

  1. akesselheim@partners.org

Authors and Affiliations

  1. Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA

    Thomas J Hwang & Daniel Carpenter

  2. The Blackstone Group, London, UK

    Thomas J Hwang

  3. George Washington University School of Medicine, Washington, DC, USA

    John H Powers

  4. Radcliffe Institute for Advanced Study, Harvard University, Cambridge, Massachusetts, USA

    Daniel Carpenter

  5. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Program on Regulation, Therapeutics, and Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA

    Aaron S Kesselheim

Authors
  1. Thomas J Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John H Powers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel Carpenter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aaron S Kesselheim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Thomas J Hwang or Aaron S Kesselheim.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figure

Supplementary Figure 1 (PDF 304 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hwang, T., Powers, J., Carpenter, D. et al. Accelerating innovation in rapid diagnostics and targeted antibacterials. Nat Biotechnol 33, 589–590 (2015). https://doi.org/10.1038/nbt.3251

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3251

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation